RESEARCH NOTE
·
Immuron Ltd (IMC)
Should we invest in this biopharmaceutical company at the current levels?
Healthcare
Daily
ASX
This report is available to subscribers
The full research note on Immuron Ltd — our view, the levels we are working to and the reasoning behind them — is part of a Kapitales subscription.